Literature DB >> 16824040

Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages.

Susan L Fink1, Brad T Cookson.   

Abstract

Salmonella enterica serovar Typhimurium invades host macrophages and induces a unique caspase-1-dependent pathway of cell death termed pyroptosis, which is activated during bacterial infection in vivo. We demonstrate DNA cleavage during pyroptosis results from caspase-1-stimulated nuclease activity. Although poly(ADP-ribose) polymerase (PARP) activation by fragmented DNA depletes cellular ATP to cause lysis during oncosis, the rapid lysis characteristic of Salmonella-infected macrophages does not require PARP activity or DNA fragmentation. Membrane pores between 1.1 and 2.4 nm in diameter form during pyroptosis of host cells and cause swelling and osmotic lysis. Pore formation requires host cell actin cytoskeleton rearrangements and caspase-1 activity, as well as the bacterial type III secretion system (TTSS); however, insertion of functional TTSS translocons into the host membrane is not sufficient to directly evoke pore formation. Concurrent with pore formation, inflammatory cytokines are released from infected macrophages. This mechanism of caspase-1-mediated cell death provides additional experimental evidence supporting pyroptosis as a novel pathway of inflammatory programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824040     DOI: 10.1111/j.1462-5822.2006.00751.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  424 in total

1.  Regulation of phenotypic heterogeneity permits Salmonella evasion of the host caspase-1 inflammatory response.

Authors:  Mary K Stewart; Lisa A Cummings; Matthew L Johnson; Alex B Berezow; Brad T Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  Regulating caspase-1 during infection: roles of NLRs, AIM2, and ASC.

Authors:  Christopher L Case
Journal:  Yale J Biol Med       Date:  2011-12

3.  The Inflammasome Adaptor ASC Induces Procaspase-8 Death Effector Domain Filaments.

Authors:  Parimala R Vajjhala; Alvin Lu; Darren L Brown; Siew Wai Pang; Vitaliya Sagulenko; David P Sester; Simon O Cridland; Justine M Hill; Kate Schroder; Jennifer L Stow; Hao Wu; Katryn J Stacey
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

Review 4.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

Review 5.  Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis.

Authors:  Alexander Wree; Wajahat Z Mehal; Ariel E Feldstein
Journal:  Semin Liver Dis       Date:  2016-02-12       Impact factor: 6.115

6.  Asc and Ipaf Inflammasomes direct distinct pathways for caspase-1 activation in response to Legionella pneumophila.

Authors:  Christopher L Case; Sunny Shin; Craig R Roy
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

7.  Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain.

Authors:  Nicole B Bryan; Andrea Dorfleutner; Yon Rojanasakul; Christian Stehlik
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 8.  Mechanism and Regulation of NLRP3 Inflammasome Activation.

Authors:  Yuan He; Hideki Hara; Gabriel Núñez
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

9.  K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling.

Authors:  Michael A Katsnelson; L Graham Rucker; Hana M Russo; George R Dubyak
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

Review 10.  Inflammasomes and its importance in viral infections.

Authors:  Gaurav Shrivastava; Moisés León-Juárez; Julio García-Cordero; David Eduardo Meza-Sánchez; Leticia Cedillo-Barrón
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.